TELA Bio (TELA) Return on Capital Employed (2019 - 2026)

TELA Bio's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 58.47% for Q1 2026.

• On a quarterly basis, Return on Capital Employed rose 235.0% year-over-year to 58.47% in Q1 2026; TTM through Mar 2026 was 58.47%, a 235.0% increase from a year earlier, with the FY2025 full-year figure at 51.13%, up 1.0% from the prior year.
• Return on Capital Employed grew to 58.47% in Q1 2026 per TELA's latest filing, from 63.06% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 54.6% in Q3 2023 and bottomed at 95.69% in Q3 2024.
• The 5-year median for Return on Capital Employed is 67.07% (2023), against an average of 69.61%.
• Across the five-year window, Return on Capital Employed slumped 4339 bps in 2022 and surged 2117 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 63.63% in 2022, then decreased by 5 bps to 67.07% in 2023, then rose by 6 bps to 62.95% in 2024, then slipped by 0 bps to 63.06% in 2025, then advanced by 7 bps to 58.47% in 2026.
• Per Business Quant, the three latest TELA Return on Capital Employed figures stand at 58.47% (Q1 2026), 63.06% (Q4 2025), and 74.52% (Q3 2025).